Medicare Enrolled
Dr. Michael Radin, M.D.
Cardiovascular Disease · Newport Beach, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Radin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Radin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Radin
Dr. Michael Radin is a cardiovascular disease specialist in Newport Beach, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Radin performed 5,382 Medicare services across 2,411 unique beneficiaries.
Between the years covered by Open Payments, Dr. Radin received a total of $8,565 from 33 pharmaceutical and/or device companies across 355 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Radin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 17% volume in CA
$8,565 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,382
Medicare services
Top 17% in CA for cardiovascular disease
2,411
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~283 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
900 | $140 | $387 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
768 | $34 | $100 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
730 | $42 | $119 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
634 | $12 | $66 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
551 | $45 | $139 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
536 | $97 | $261 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
147 | $170 | $641 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
110 | $50 | $100 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
101 | $17 | $75 |
| Autonomic nervous system testing with heart rate response to deep breathing This test evaluates the function of the autonomic nervous system by measuring how the heart rate changes in response to deep breathing. |
98 | $78 | $200 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
97 | $112 | $300 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
92 | $47 | $72 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
88 | $21 | $148 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
88 | $787 | $2,249 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
87 | $118 | $500 |
| New patient office visit, complex (60-74 min) | 68 | $185 | $519 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
59 | $59 | $228 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
52 | $76 | $200 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
38 | $82 | $260 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
30 | $403 | $1,500 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $76 | $210 |
| Additional 30 minutes of principal care management This service covers each additional 30 minutes of clinical staff time directed by a healthcare professional for managing a single high-risk disease, billed per calendar month. |
28 | $41 | $90 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
23 | $55 | $317 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
15 | $72 | $119 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
14 | $222 | $550 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.0% high complexity
6.9% medium
90.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,565
Total received (2018-2024)
Avg $1,224/year across 7 years
Top 30% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
355
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,383 (97.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$181 (2.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$826
2023
$705
2022
$833
2021
$1,305
2020
$645
2019
$2,521
2018
$1,731
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$153
AstraZeneca Pharmaceuticals LP
$125
Novo Nordisk Inc
$99
SANOFI-AVENTIS U.S. LLC
$77
Novartis Pharmaceuticals Corporation
$65
Merck Sharp & Dohme LLC
$62
Kiniksa Pharmaceuticals International, plc
$47
SCPHARMACEUTICALS INC.
$46
PFIZER INC.
$35
Impulse Dynamics (USA) Inc.
$34
Philips North America LLC
$33
Janssen Scientific Affairs, LLC
$28
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
Top 3 companies account for 45.6% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$1,552
Novartis Pharmaceuticals Corporation
$845
Amarin Pharma Inc.
$819
Amgen Inc.
$785
SANOFI-AVENTIS U.S. LLC
$713
AstraZeneca Pharmaceuticals LP
$632
Janssen Pharmaceuticals, Inc
$468
BIOTRONIK INC.
$314
Gilead Sciences, Inc.
$284
Regeneron Healthcare Solutions, Inc.
$260
BOSTON SCIENTIFIC CORPORATION
$244
Boehringer Ingelheim Pharmaceuticals, Inc.
$230
Philips Electronics North America Corporation
$169
Merck Sharp & Dohme LLC
$132
Impulse Dynamics (USA) Inc.
$127
E.R. Squibb & Sons, L.L.C.
$124
PFIZER INC.
$114
Esperion Therapeutics, Inc.
$110
Novo Nordisk Inc
$99
Astellas Pharma US Inc
$83
SCPHARMACEUTICALS INC.
$83
ARBOR PHARMACEUTICALS, INC.
$69
Kiniksa Pharmaceuticals International, plc
$47
Arbor Pharmaceuticals, Inc.
$43
Philips North America LLC
$33
Braemar Manufacturing, LLC
$33
Kowa Pharmaceuticals America, Inc.
$32
Abbott Laboratories
$31
Janssen Scientific Affairs, LLC
$28
Lundbeck LLC
$18
Edwards Lifesciences Corporation
$16
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$14
Merck Sharp & Dohme Corporation
$13
Top 3 companies account for 37.5% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (7999) SRC Undivided · (9280) LM Accessories · Arcalyst · Assurity Pacemaker · BRILINTA · CONFIRM RX · Cardiac Monitoring Suite · Corlanor · ELIQUIS · EMBLEM · ENTRESTO · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · FASENRA · FUROSCIX · GENERAL BRADY · GENERAL TACHY · GENERAL THERAPIES · GENERAL - TACHY · GENERAL TACHY · GENERAL THERAPIES · General - Therapies · Horizant · JARDIANCE · LATITUDE · LEQVIO · LEXISCAN · LUX DX · LifeVest · Livalo · MULTAQ · NEXLETOL · NORTHERA · OPTIMIZER · Optimizer · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · RELIANCE 4 FRONT · RESONATE · Repatha · VERQUVO · VIGILANT · Vascepa · Wegovy · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
249
Per 100K population
7.9
County median income
$113,702
Nearest hospital
HOAG MEMORIAL HOSPITAL PRESBYTERIAN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Radin is a clinical cardiology specialist, with above-average Medicare volume (top 17% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Radin experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Radin performed 900 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Radin receive payments from pharmaceutical companies?
Yes. Dr. Radin received a total of $8,565 from 33 companies across 355 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Radin's costs compare to other cardiologists in Newport Beach?
Dr. Radin's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Radin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Newport Beach
Browse cardiologists in Newport Beach ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amarin Pharma Inc. Payments to Doctors
See all physicians who received payments from Amarin Pharma Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology